We have studied the abilities of different transactivation domains to
stimulate the initiation and elongation (postinitiation) steps of RNA
polymerase II transcription in vivo Nuclear run-on and RNase protectio
n analyses revealed three classes of activation domains: Spl and CTF s
timulated initiation (type I); human immunodeficiency virus type I Tat
fused to a DNA binding domain stimulated predominantly elongation (ty
pe IIA); and VP16, p53, and E2F1 stimulated both initiation and elonga
tion (type IIB). A quadruple point mutation of VP16 converted it from
a type IIB to a type I activator. Type I and type IIA activators syner
gized with one another but not with type IIB activators. This observat
ion implies that synergy can result from the concerted action of facto
rs stimulating two different steps in transcription: initiation and el
ongation. The functional differences between activators may be explain
ed by the different contacts they make with general transcription fact
ors. In support of this idea, we found a correlation between the abili
ties of activators, including Tat, to stimulate elongation and their a
bilities to bind TFIIH.